2004
DOI: 10.1002/14651858.cd002025.pub2
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Buprenorphine for the management of opioid withdrawal

Search citation statements

Order By: Relevance

Paper Sections

Select...
59
1
0
0

Citation Types

0
4
0
0

Year Published

Range
2001
2001
2024
2024

Publication Types

Select...
46
8
5

Relationship

0
59

Authors

Journals

citations

Cited by 59 publications

(4 citation statements)
references

References 0 publications

0
4
0
0
Order By: Relevance
How this paper cites the one you are viewing
“…16,17 The present results are consistent with findings from other studies that have found some superiority of buprenorphine over methadone detoxification. 8,11 Detoxification with buprenorphine plus carbamazepine has been shown to be superior to methadone plus carbamazepine. 18 Other studies have reported buprenorphine and methadone to be of comparable effectiveness.…”
Section: Discussion
mentioning
confidence: 99%
“…Buprenorphine, prescribed in reducing doses, has been found to be more effective than adrenergic agonists in alleviating opiate withdrawal symptoms 8 and of broadly comparable effectiveness to methadone. 9,10 Better treatment retention has been found among patients treated with buprenorphine than with methadone, 11 and opiate withdrawal symptoms may resolve more rapidly after treatment with buprenorphine than with methadone.…”
mentioning
confidence: 99%
“…9,10 Better treatment retention has been found among patients treated with buprenorphine than with methadone, 11 and opiate withdrawal symptoms may resolve more rapidly after treatment with buprenorphine than with methadone. 8 The present study is a preliminary investigation of the effectiveness of buprenorphine and methadone as detoxification treatments for opiate-dependent inpatients. Study limitations include the use of an open-label design and nonrandom assignment of patients.…”
mentioning
confidence: 99%
See 2 more Smart Citations